2-methylprop anamides and their use as pharmaceuticals
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 30, 2010
Grant Date -
Dec 29, 2005
app pub date -
Jun 23, 2005
filing date -
Jun 24, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully